Status:
UNKNOWN
Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope
Lead Sponsor:
HaEmek Medical Center, Israel
Collaborating Sponsors:
Carmel Medical Center
Conditions:
Respiratory Distress Syndrome
Eligibility:
All Genders
30-36 years
Phase:
NA
Brief Summary
In this study the investigators intend to assess the feasibility of surfactant administration via a thin catheter using a specially adapted video laryngoscope, with a groove designed to allow insertio...
Detailed Description
A prospective study to assess the safety and efficacy of surfactant administration via thin catheter using a specially adapted VNscope, originally used for endotracheal intubation and adapted for the ...
Eligibility Criteria
Inclusion
- \- Premature infants with gestational age 30-36 weeks.
- \- Diagnosis of respiratory distress syndrome
- \- Treatment with antenatal steroids.
- \- Spontaneously breathing with non-invasive positive pressure ventilation.
- \- maximal age 3 days.
Exclusion
- \- Apgar score at 5 min \< 5
- \- Need for chest compressions or medication upon delivery.
- \- Evident major congenital malformation, metabolic or genetic disorders.
- \- Clinical evidence of sepsis.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03846960
Start Date
November 1 2019
End Date
December 1 2021
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haemek medical centre
Afula, Israel